• FirefoxInstall the new Firefox »
  •  Dow Down0.44% Nasdaq Down0.42%

    Cytokinetics, Incorporated (CYTK)

    -NasdaqCM
    7.00 Up 0.22(3.24%) 4:00PM EDT
    |After Hours : 7.00 Down 0.01 (0.14%) 4:00PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 46,940   30,648   7,559  
    Cost of Revenue -   -   -  
    Gross Profit 46,940   30,648   7,559  
    Operating Expenses
    Research Development44,426  49,450  35,643  
    Selling General and Administrative17,268  15,092  12,429  
    Non Recurring -   -  (56)
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (14,754) (33,894) (40,457)
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -  
    Earnings Before Interest And Taxes(14,646)(33,717)(40,370)
    Interest Expense -   -   -  
    Income Before Tax(14,646)(33,717)(40,370)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(14,646)(33,717)(40,370)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (14,646) (33,717) (40,370)
    Preferred Stock And Other Adjustments -   -  (1,307)
    Net Income Applicable To Common Shares (14,646) (33,717) (41,677)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.